Does Dr. ROBERT MONTGOMERY have financial conflicts of interest?

Dr. ROBERT MONTGOMERY (M.D.) has received a total of $105,029 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $104,238 in personal promotional payouts (consulting, meals, travel) and $791 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. ROBERT MONTGOMERY?

According to CMS Open Payments data, Dr. ROBERT MONTGOMERY received funding from SANOFI-AVENTIS U.S ($83,643), ALEXION PHARMACEUTICALS ($7,378), and OCTAPHARMA USA ($6,589).

Does Dr. ROBERT MONTGOMERY receive research grants or speaking fees?

Dr. ROBERT MONTGOMERY has received $104,238 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $791 in clinical research grants.

DR. ROBERT MONTGOMERY

M.D.Real-Time Hydrated

Specialty: Transplant Surgery

Practice Location: BALTIMORE, MD 21287

NPI Number: 1467404137

LIFETIME INDUSTRY VALUE

$105,029

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. MONTGOMERY is a verified Transplant Surgery practitioner based in BALTIMORE, MD.

Between 2021 and 2025, Dr. MONTGOMERY had an overall industry promotional and research financial footprint of $105,029 as recorded in the federal CMS Open Payments database.

$104,238 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$791 was allocated to sponsored clinical trials and medical research activities.

Dr. MONTGOMERY's primary funding source is SANOFI-AVENTIS U.S, which accounts for $83,643 (representing 79.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SANOFI-AVENTIS U.S

Rank 1

$83,643

79.6%

ALEXION PHARMACEUTICALS

Rank 2

$7,378

OCTAPHARMA USA

Rank 3

$6,589

6.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.